The frequencies of differences between highest and lowest subtest scores as a function of highest subtest score (relative scatter), are reported for the standardization sample of the Wechsler Adult Intelligence Scale-IV (WAIS-IV). Large differences between highest and lowest subtest scores were common. The degree of relative scatter was related to the height of the highest subtest score. For the 10 core WAIS-IV subtests, the correlation between the level of the highest subtest score and the amount of scatter was r = .62; for all 15 subtests the correlation was. 63. The level of the highest subtest score was more strongly related to scatter than was Full Scale IQ. Clinical implications for inferring cognitive impairment and estimating premorbid abilities are discussed. When considering the possibility of acquired cognitive impairment, we recommend caution in the interpretation of subtest score differences.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/13854046.2010.533195 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical Manifestations.
Alzheimers Dement
December 2024
Research Program on Cognition and Neuromodulation-Based Interventions, University of Michigan, Ann Arbor, MI, USA.
Background: The computerized NIH Toolbox Cognition Battery (NIHTB-CB) was designed to assess cognitive functioning across the lifespan. Previous studies demonstrated that NIHTB-CB measures discriminate between healthy controls (HCs), individuals with amnestic mild cognitive impairment (aMCI), and individuals with dementia of the Alzheimer's type (DAT). Scores on NIHTB-CB tasks also correspond with performance on well-validated neuropsychological measures of the same cognitive domains.
View Article and Find Full Text PDFClinical Manifestations.
Alzheimers Dement
December 2024
University of California, San Diego, La Jolla, CA, USA.
Background: Women are more likely to experience sleep problems than men, especially during and after menopausal transition. Sleep disturbances are related to memory decline and the development of Alzheimer's disease (AD), which is also more common among women. While research on habitual sleep patterns in aging has largely focused on mean sleep outcomes across nights, few studies have examined the potentially harmful effects of night-to-night variability in sleep quality on AD biomarkers and memory function.
View Article and Find Full Text PDFClinical Manifestations.
Alzheimers Dement
December 2024
Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Background: Repeated self-administered mobile-based cognitive assessments are increasingly being utilized to identify preclinical cognitive decline. Repetition of cognitive tests during a short time interval often leads to improved performance (i.e.
View Article and Find Full Text PDFClinical Manifestations.
Alzheimers Dement
December 2024
Veterans Affairs Northern California Health Care System, Martinez, CA, USA.
Background: Similar neuroimaging abnormalities are reported in post-COVID patients and patients with AD. Moreover, COVID-19 and Alzheimer's Disease (AD) share genetic vulnerabilities and have similar cognitive symptoms of COVID (e.g.
View Article and Find Full Text PDFClinical Manifestations.
Alzheimers Dement
December 2024
Consortium pour l'Identification précoce de la Maladie d'Alzheimer - Québec, Montréal/Québec/Sherbrooke, QC, Canada.
Background: Olfactory identification is impaired in the early stages of Alzheimer's disease (AD), including mild cognitive impairment (MCI). This early sensory impairment could result from several factors such as early cognitive or structural cerebral damages caused by the disease. It is however not clear which factors are contributing the most to the olfactory impairment in older people at risk of developing AD.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!